Liu S, Liu Y, Lu Q, Zhou X, Chen L, Liang W. The lncRNA TUG1 promotes epithelial ovarian cancer cell proliferation and invasion via the WNT/β-catenin pathway. OncoTargets and Therapy. 2018:11;6845–6851.
The Editor-in-chief and Publisher of OncoTargets and Therapy wish to retract the published article.
Subsequent to publication, it was found the above article contained significantly similar text from several other articles: Long non-coding RNA ANRIL indicates a poor prognosis of cervical cancer and promotes carcinogenesis via PI3K/Akt pathways by Dongli Zhang, Guixia Sun, Hongxia Zhang, Jun Tian, Yanyun Li. Biomedicine and Pharmacotherapy. 2017;85:511–516. https://doi.org/10.1016/j.biopha.2016.11.058
LncRNA TUG1 promotes cell proliferation and suppresses apoptosis in osteosarcoma by regulating miR-212-3p/FOXA1 axis by Chuhai Xie, Binwei Chen, Boyi Wu, Jianhong Guo, Yanming Cao. Biomedicine and Pharmacotherapy. 2018;97:1645–1653. https://doi.org/10.1016/j.biopha.2017.12.004
Long non-coding RNA PCAT-1 over-expression promotes proliferation and metastasis in gastric cancer cells through regulating CDKN1A by Mingjun Bi, Hongmei Yu, Bin Huang, Cuiyan Tang. Gene. 2017;626:337–343. https://doi.org/10.1016/j.gene.2017.05.049
LncRNA TRERNA1 Function as an Enhancer of SNAI1 Promotes Gastric Cancer Metastasis by Regulating Epithelial-Mesenchymal Transition by Huazhang Wu, Ying Hu, Xiufang Liu, Wei Song, Pihai Gong, Kun Zhang, Zhenxing Chen, Menghan Zhou, Xiahui Shen, Yanyan Qian, Hong Fan. Molecular Therapy Nucleic Acids. 2017;8:291–299. https://doi.org/10.1016/j.omtn.2017.06.021
Both the authors and the authors affiliated institution were contacted to provide an explanation but no response was received.